Companies / Black Diamond Therapeutics, Inc. / Activity
Activity — Black Diamond Therapeutics, Inc.
7 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Mar 20, 2026 | Behbahani Ali Director | Grant | Common Stock | $14.9K | +7K +7.99% | 93,568 0.16% of shares | low |
| Mar 20, 2026 | Raman Prakash Director | Grant | Common Stock | $13.1K | +6K +19.68% | 37,132 0.06% of shares | low |
| Jan 21, 2026 | Velleca Mark A. CEO | Grant | Stock Option (Right to Buy) | — | +600K | 600,000 1.04% of shares | low |
| Jan 21, 2026 | Jones Erika Executive | Grant | Stock Option (Right to Buy) | — | +200K | 200,000 0.35% of shares | low |
| Jan 21, 2026 | Buck Elizabeth Executive | Grant | Stock Option (Right to Buy) | — | +250K | 250,000 0.44% of shares | low |
| Jan 21, 2026 | Yurasov Sergey Executive | Grant | Stock Option (Right to Buy) | — | +250K | 250,000 0.44% of shares | low |
| Jan 21, 2026 | Hatzis-Schoch Brent Executive | Grant | Stock Option (Right to Buy) | — | +250K | 250,000 0.44% of shares | low |